Literature DB >> 8258994

Separation of rare cell subpopulations with the aid of biotin-labelled ligands.

M Steinitz1, A Livoff, S Tamir, T Brenner.   

Abstract

A universal method for selection of surface marker-positive cells is described. The cells, admixed with an excess of surface marker-negative cells, are first labelled with a specific biotinylated ligand and then isolated with the aid of monoclonal, anti-biotin coated beads. The method enables selection and isolation of cells with a frequency as low as 10(-4). The ligand can be an antigen (for selection of infrequent antibody-producing cells), an antibody (for selection of surface antigen-positive cells) or other molecules (for selection of specific receptor-positive cells).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258994     DOI: 10.1007/bf02987768

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  14 in total

1.  Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

Authors:  J Menezes; W Leibold; G Klein; G Clements
Journal:  Biomedicine       Date:  1975-07

Review 2.  Recombinant antibodies.

Authors:  J W Larrick; K E Fry
Journal:  Hum Antibodies Hybridomas       Date:  1991-10

3.  Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes.

Authors:  R R Coombs; A B Wilson; O Eremin; B W Gurner; D G Haegert; Y A Lawson; S Bright; A J Munro
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

Review 4.  Human monoclonal antibody production. Current status and future prospects.

Authors:  K James; G T Bell
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

5.  Identification of subpopulations of T lymphocytes and Ia positive B lymphocytes using a rosette assay based upon the biotin-avidin interaction.

Authors:  R J Mason; K N Stewart; D A Power; A M MacLeod; G R Catto
Journal:  Immunol Lett       Date:  1983       Impact factor: 3.685

6.  In vitro produced monoclonal rheumatoid factor: purification, radiolabel, and possible applications.

Authors:  M Steinitz; N Koide; G Spira; S Tamir; G Klein
Journal:  Cell Immunol       Date:  1982-05-15       Impact factor: 4.868

7.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.

Authors:  M Steinitz; S Tamir; J E Frödin; A K Lefvert; H Mellstedt
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

9.  Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes.

Authors:  M Steinitz; G Izak; S Cohen; M Ehrenfeld; I Flechner
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

10.  Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA).

Authors:  C Kendall; I Ionescu-Matiu; G R Dreesman
Journal:  J Immunol Methods       Date:  1983-02-11       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.